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Abstract
Background: In order to ensure precise chromosome duplication, eukaryotes "license" their
replication origins during late mitosis and early G1 by assembling complexes of Mcm2-7 onto them.
Mcm2-7 are essential for DNA replication, but are displaced from origins as they initiate, thus
ensuring that no origin fires more than once in a single cell cycle.
Results: Here we show that a combination of purified nucleoplasmin, the origin recognition
complex (ORC), Cdc6, RLF-B/Cdt1 and Mcm2-7 can promote functional origin licensing and the
assembly of Mcm2-7 onto Xenopus sperm nuclei. The reconstituted reaction is inhibited by geminin,
a specific RLF-B/Cdt1 inhibitor. Interestingly, the purified ORC used in the reconstitution had
apparently lost the Orc6 subunit, suggesting that Orc6 is not essential for replication licensing. We
use the reconstituted system to make a preliminary analysis of the different events occuring during
origin assembly, and examine their nucleotide requirements. We show that the loading of Xenopus
ORC onto chromatin is strongly stimulated by both ADP, ATP and ATP-γ -S whilst the loading of
Cdc6 and Cdt1 is stimulated only by ATP or ATP-γ -S.
Conclusions:  Nucleoplasmin, ORC, Cdc6, RLF-B/Cdt1 and Mcm2-7 are the only proteins
required for functional licensing and the loading of Mcm2-7 onto chromatin. The requirement for
nucleoplasmin probably only reflects a requirement to decondense sperm chromatin before ORC
can bind to it. Use of this reconstituted system should allow a full biochemical analysis of origin
licensing and Mcm2-7 loading.
Background
During S phase of the eukaryotic cell division cycle the
entire genome must be faithfully duplicated. The many
thousands of replication forks involved in this process
must be co-ordinated to ensure that, despite the very
large quantities of DNA involved, no section of DNA is
left unreplicated and no section of DNA is replicated
more than once. Cells achieve this by dividing the proc-
ess of replication origin activation into two distinct phas-
es [1–3]. During late mitosis and early G1, proteins are
assembled onto replication origins which culminates in
the origin becoming 'licensed' for a single round of DNA
replication by loading complexes of Mcm2-7 proteins
[4–8]. In yeast, a 'pre-replicative complex' (pre-RC)
forms a footprint over replication origins during G1 [9]
which may well correspond to the Mcm2-7 loading that
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represents the licensed state, although it is possible that
other factors in addition to those required for origin li-
censing are involved. During S phase, replication forks
are initiated at licensed replication origins / pre-RCs fol-
lowing activation of the Cdc7 kinase and S phase cyclin-
dependent kinases (CDKs). Mcm2-7 are displaced from
the origin as initiation occurs, thereby ensuring that each
origin fires no more than once in each cell cycle. Follow-
ing displacement from origins, Mcm2-7 appear to move
along with the replication fork [10], consistent with their
providing essential helicase activity for the progression
of the replication fork [11].
Three other proteins are known to be required for licens-
ing replication origins and loading of Mcm2-7 onto them
[1,2,12]: the Origin Recognition Complex (ORC), Cdc6
and RLF-B/Cdt1 [13–19]. ORC is first required on the
DNA in order to recruit Cdc6 and RLF-B/Cdt1. The con-
tinued presence of ORC, Cdc6 and RLF-B/Cdt1 are not
required for Mcm2-7 to remain bound to DNA once li-
censing has occurred [18,20–22]. By restricting the ac-
tivity of ORC, Cdc6 or RLF-B/Cdt1 to a period between
late mitosis and the end of G1, the relicensing of replicat-
ed origins can therefore be prevented. At least two activ-
ities present at other periods of the cell cycle, geminin
(an RLF-B/Cdt1 inhibitor) and CDKs, are known to in-
hibit origin licensing and pre-RC assembly
[1,2,12,19,23].
In order to understand how origin licensing and Mcm2-
7 loading are regulated, we have been purifying from
Xenopus egg extracts all the proteins required to support
functional origin licensing [3]. We chose Xenopus sperm
nuclei as the DNA template because it is the natural sub-
strate for replication in Xenopus eggs and because it is
replicated very efficiently in the cell-free system. Using
this assay we have previously shown that the licensing of
Xenopus sperm nuclei requires ORC, Cdc6, RLF-B/Cdt1
and Mcm2-7 [5,15,16,19]. We have also shown that this
process requires nucleoplasmin [24], which is needed to
remove the sperm basic proteins from sperm nuclei and
decondense the chromatin [25,26], which in turn is re-
quired for ORC to bind to the chromatin [24].
In the present report we show that a combination of
these purified proteins (nucleoplasmin, ORC, Cdc6,
RLF-B/Cdt1 and Mcm2-7) can efficiently license Xeno-
pus sperm nuclei and assemble Mcm2-7 onto it. We
show that the reconstituted reaction is dependent on
ATP and is inhibited by geminin. We use the reconstitut-
ed system to make a preliminary analysis of the different
events occuring during the licensing of replication ori-
gins.
Results
Characterization of protein fractions
We have been performing a systematic fractionation of
Xenopus egg extracts to identify all the proteins required
to reconstitute functionally licensed replication origins
on Xenopus sperm nuclei [5,8,15,16,19,24,27]. The se-
quential separation of activities present in whole egg ex-
tract is summarised in Figure 1. Preliminary
reconstitution experiments suggested that a combina-
tion of nucleoplasmin, ORC, Cdc6, RLF-B/Cdt1, and
Mcm2-7 were sufficient to support efficient origin licens-
ing of Xenopus sperm nuclei (PJG, data not shown).
During the fractionation, no additional activities that
stimulate origin licensing were observed
[[5,8,15,16,19,24,27] and data not shown]. In addition to
this scheme, we also prepared three of the proteins (nu-
cleoplasmin, Cdc6 and RLF-B/Cdt1) by different means.
Nucleoplasmin was purified by a different published
protocol [24,28], recombinant Cdc6 was prepared from
baculovirus-infected insect cells [14] and recombinant
RLF-B/Cdt1 was prepared from Escherichia coli[18,19].
Figure 2 shows Coomassie gels of the purified proteins.
Purified nucleoplasmin showed a number of different
bands that correspond to different phosphorylated forms
[28,29] (Fig 2a). Purified ORC yielded 5 specific bands,
corresponding to XOrc1, 2, 3, 4 and 5 [15,30–32] (Fig
2b). No band corresponding to XOrc6 was observed, and
to date no Xenopus ORC6 gene has been cloned. ORC
purified from HeLa cell chromatin has also been report-
ed to lack Orc6 [33], and in S. cerevisiae Orc6 is not re-
quired for ORC to bind origin DNA [34]. We also
observed two additional proteins that contaminate the
Xenopus ORC preparation [15]. These proteins were
Figure 1
Fractionation scheme for proteins used in this study. Inter-
phase Xenopus egg extract was fractionated by the methods
outlined. See Materials and Methods for more details. Cdc6
was not purified to homogeneity but was replaced in the
reconstituted reaction with recombinant material produced
in insect cells.BMC Biochemistry 2001, 2:15  http://www.biomedcentral.com/1471-2091/2/15
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subjected to MALDI-TOF analysis and were identified as
Xenopus Klp1 and Kcm1 [35,36]. The chromatographic
behaviour of these proteins suggests that they do not
form complexes with ORC [[15] and data not shown].
Further, immunodepletion of ORC from Xenopus egg ex-
tracts did not co-deplete XKlp1 (data not shown). We
therefore conclude that Klp1 and Kcm1 are fortuitous
contaminants of our ORC preparation. Recombinant
Xenopus Cdc6 (Fig 2c) [14], purified RLF-B/Cdt1 (Fig
2d) [19] and recombinant ∆ Cdt1 (amino acids 141–621 of
Xenopus Cdt1, Fig 2e) [18] showed a single band of the
expected molecular weight. Complexes of Xenopus
Mcm(2+4+6+7) and Mcm(3+5) were purified from
Xenopus egg extracts as described [24,27] (Figs 2f and
2g). The Mcm(3+5) contained two contaminating bands
of ~52 and ~58 kDa, which we were unable to identify by
mass spectrometry. However, their chromatographic be-
haviour suggests that they are not components of the
Mcm2-7 complex [24,27]. Recombinant geminin was
prepared from E. coli as described (Fig 2h) [37].
Specific assays for individual proteins
In order to minimise the risk that any of these fractions
were contaminated with other activities required for ori-
gin licensing, we wanted to ensure that each of them was
used in the reconstitution at limiting quantities. We
therefore titrated each of the purified fractions into a
separate assay that was specific for each activity (Fig 3).
Nucleoplasmin reached an optimum at ~4 ng / ng tem-
plate DNA for both a crude licensing reaction (Fig 2a)
and sperm decondensation [24]. This is approximately
equal to 1 nucleoplasmin pentamer for each 64 bp DNA,
close to the expected density of protamines on sperm
DNA and consistent with the role of nucleoplasmin being
to decondense the chromatin by removal of protamines
[24].
ORC was assayed by titrating into an extract previously
immunodepleted with anti-Orc1 antibodies, an assay
specific for licensing activities co-depleted with ORC (Fig
3b). Purified ORC reached an optimum at ~85 pg / ng
DNA, equal to one molecule of ORC per ~6 kb template
Figure 2
Purified proteins used in this study. Purified proteins were
run on SDS polyacrylamide gels, and visualized with either
Coomassie Blue (a-c, e-h) or silver staining (d). a, Nucleo-
plasmin purified from Xenopus eggs. b, ORC purified from
Xenopus eggs. c, Recombinant Xenopus Cdc6 purified from
baculovirus-infected insect cells. d, RLF-B/Cdt1 purified from
Xenopus eggs. e, Recombinant Xenopus ∆ Cdt1 purified from
E. coli.f, Mcm(2+4+6+7) purified from Xenopus eggs. g,
Mcm(3+5) purified from Xenopus eggs. h, Recombinant Xeno-
pus geminin purified from E. coll.
Figure 3
Activity of the purified proteins. Different quantities of puri-
fied proteins were subjected to specific individual assays,
using Xenopus sperm nuclei as substrate. Protein quantity is
given as mass of protein per ng template DNA (a-f) or mass
of protein per µl extract (g). DNA synthesis is expressed as
% of the DNA template replicated (a-f), or ng DNA synthe-
sised per µl extract (g). a, Nucleoplasmin activity required in
a crude licensing assay. b, ORC activity required for licensing
in an ORC-depleted extract. c, Cdc6 activity required for
licensing in an Cdc6-depleted extract. d, e, RLF-B activity
required in a crude licensing assay. f, RLF-M/Mcm2-7 activity
required in an Mcm2-7-depleted extract. g, Replication inhi-
bition by geminin in whole egg extract containing 3 ng/µl
DNA. Arrows show the protein quantity used in subsequent
reconstitution experiments.BMC Biochemistry 2001, 2:15  http://www.biomedcentral.com/1471-2091/2/15
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DNA. This is close to the expected density of ORC on
Xenopus sperm chromatin in the early embryo (~1 ORC
per 10–15 kb) [15] and close to the spacing of replication
origins on sperm chromatin (1 origin every ~10 kb) [38].
It is notable that the purified ORC, lacking detectable
Orc6, can efficiently restore activity to ORC-depleted ex-
tracts.
Recombinant Cdc6 was assayed by titrating into an ex-
tract previously immunodepleted with anti-Cdc6 anti-
bodies, an assay specific for Cdc6 or activities co-
depleted with it (Fig 3c). Recombinant Cdc6 restored li-
censing (50% of the template) at 0.75 ng / ng template
DNA. This represents 1 molecule of Cdc6 per ~125 bp
DNA, somewhat higher than is available in whole egg ex-
tract [14]. This suggests that, consistent with previous re-
ports [14], the recombinant protein is only partially
active.
When purified RLF-B/Cdt1 was titrated into a crude li-
censing assay, no plateau of activity was reached value,
with 20–25% of template becoming licensed with ~0.6
pg / ng DNA template, equal to one molecule of RLF-B/
Cdt1 per ~35 kb template DNA (Fig 3d). In a similar as-
say, recombinant ∆ Cdt1 supported licensing (~60% of
the template) at ~0.12 ng / ng template DNA (Fig 2e),
which represents 1 molecule ∆ Cdt1 per ~700 bp template
DNA. Like the recombinant Cdc6, recombinant ∆ Cdt1
therefore appears to have lower specific activity than the
protein purified from whole egg extract.
Purified Mcm2-7 was produced by mixing equal quanti-
ties of the Mcm(3+5) dimer and the Mcm(2+4+6+7) te-
tramer [24,27]. It was assayed by titration into an extract
previously immunodepleted with anti-Mcm3 and Mcm7
antibodies, an assay specific for Mcm2-7 or activities co-
depleted with them. The activity of purified Mcm2-7
started to plateau at about 1.25 ng / ng template DNA
(Fig 3f). This corresponds to 1 heterohexamer per ~700
bp template DNA, close to the Mcm2-7 density found on
sperm chromatin in whole egg extract [39]. The difficulty
in providing enough Mcm2-7 activity appears largely to
be due to having to keep the proteins at high enough con-
centration (~600 µg / ml in whole egg extract), whilst the
specific activity of the purified proteins remains fairly
high [24,39].
Recombinant geminin was assayed by its ability to inhib-
it licensing in whole egg extract. Since this appears to be
related more to the concentration of RLF-B/Cdt1 in
whole extract (~200 pg / µl) rather than the concentra-
tion of DNA (data not shown), we have expressed the ti-
tration in terms of ng geminin / µl extract. Fig. 2g shows
that geminin inhibits origin licensing in whole egg ex-
tract at ~1.5 ng / µl, consistent with previous reports
[19,37].
Reconstitution of origin assembly with purified proteins
We next incubated the purified proteins together with
Xenopus sperm nuclei to see if they were sufficient to
support efficient origin licensing. Since our major con-
cern here was to reduce the risk of undetected contami-
nants playing an essential role in the assay, we used all
the purified proteins at limiting concentrations as indi-
cated by the arrows in Figure 3. Origin licensing was as-
sessed in two different ways. The first was a functional
assay, based on the ability of the kinase inhibitor 6-
dimethylaminopurine (6-DMAP) to specifically block or-
igin licensing activity as originally defined in Xenopus
egg extracts [4,40,41]. Egg extracts treated with 6-DMAP
prior to exit from metaphase ("6-DMAP extracts") fail to
degrade geminin, a specific inhibitor of origin licensing
[19,23,37,42] and so will only replicate chromatin that
contains licensed replication origins. Previous work has
shown that under the assay conditions used, there is
close correlation between the number of licensed origins
and the degree of replication [38,39]. Mcm2-7 were first
shown to be involved in once-per-cell cycle replication
using this type of assay [5–8]. The second assay we used
was to detect the quantity of Mcm2-7 loaded onto the
sperm chromatin. This binding assay is slightly less sat-
isfactory than the functional assay for two reasons: first,
up to 10–20 Mcm2-7 heterohexamers can load onto each
origin, although only ~2 per origin are required to give
maximal replication rates [27,39]; second, intermediates
in the Mcm2-7 assembly pathway can bind to chromatin,
but these intermediates appear to be non-functional and
their assembly is independent of other origin proteins
[27]. We have therefore concentrated most effort on the
functional assay.
Figure 4 shows the results of assays showing that li-
censed origins can be assembled with good efficiency
(corresponding to 18–29% of origins) with a combina-
tion of purified nucleoplasmin, ORC, Cdc6, RLF-B/Cdt1
and Mcm2-7. When any one of these components was
omitted from the reaction, licensing dropped to back-
ground levels. Further, functional origin licensing corre-
lated with the assembly of Mcm7 onto the sperm
chromatin (Fig 4b; see also Fig 6 for Mcm3). The highest
activity was obtained with a preparation of RLF-B/Cdt1
taken prior to the final gel filtration step which has very
high specific activity [19] (Fig 4a). However, both the
completely purified RLF-B/Cdt1 (Fig 4c) and recom-
binant ∆ Cdt1 (Fig 4d) supported efficient origin licens-
ing. Because the efficiency of the reconstitution (Fig 4)
was not greatly lower than the activity of the individual
proteins put into the reaction (Fig 3), we conclude that
the licensing of sperm nuclei depends only on the five pu-BMC Biochemistry 2001, 2:15  http://www.biomedcentral.com/1471-2091/2/15
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rified activities and is unlikely to depend on any other
contaminating activity.
Geminin has recently been shown to form a complex
with RLF-B/Cdt1 and inhibit its function [19,23]. Fig 2
shows that complete inhibition of licensing in whole ex-
tract was achieved with geminin at 1.5 ng / µl. Figures 4c
and 4d show that at the same concentration recombinant
geminin also inhibited licensing in the reconstituted re-
action. This suggests that the inhibition of RLF-B/Cdt1
by geminin is a direct consequence of their interaction
and does not require any additional factors.
Order of assembly
We next asked whether the binding of Cdt1 and geminin
to chromatin was dependent on the other proteins. Al-
though Cdt1 has been shown to bind to chromatin in the
absence of Cdc6 in Schizosaccharomyces pombe, this
has not been shown in metazoans. Figure 5a shows that
whilst the binding of Cdt1 to chromatin depended on the
presence of ORC, it was not affected by the presence of
Cdc6. Unfortunately we could not determine whether the
binding of Cdc6 to chromatin was dependent on the
presence of RLF-B/Cdt1, because some recombinant
Cdc6 bound to decondensed chromatin even in the ab-
sence of ORC. This is different to its behaviour in whole
extract, where the binding of Cdc6 to chromatin is de-
pendent on ORC [14,16]. Two possible explanations are
that our recombinant Cdc6 preparation may contain de-
natured or precipitated protein (see above) or that the
non-specific binding of Cdc6 to sperm chromatin is nor-
mally competed by the binding of other chromatin-asso-
ciated proteins not present in our reconstitution.
We have previously shown that when recombinant gem-
inin is added to Xenopus egg extract, it associates with
sperm chromatin [19]. In Figure 5b we have investigated
the requirement for this association using purified pro-
teins. Geminin associated only weakly with decondensed
chromatin in the presence of ORC. Recruitment of gem-
inin to the chromatin was greatly stimulated by the pres-
ence of ORC and RLF-B/Cdt1. The presence of Cdc6 did
not affect the quantity of geminin bound to the chroma-
tin. This suggests that the recruitment of geminin to
chromatin is mediated by its tight association with RLF-
B/Cdt1 [19,23], which in turn is independent of Cdc6
(Fig 5a).
Nucleotide requirements
We have previously shown that the licensing of Xenopus
sperm chromatin by crude fractions requires ATP, and
this ATP requirement cannot be fulfilled by non-hydro-
lysable nucleotide analogues such as ATP-γ -S or AMP-
PNP [5]. Figure 6a shows a similar requirement for ATP
with the reconstituted system. Neither ADP nor ATP-γ -S
could substitute for ATP. Figure 6b shows the proteins
loaded onto chromatin in reactions containing these dif-
Figure 4
Reconstitution of licensing using purified proteins. a, c, d,
Licensing activity of different combinations of purified pro-
teins incubated in the presence of 2.5 mM ATP. DNA synthe-
sis is expressed as % of the DNA template replicated. b,
Western blot of Mcm7 loaded onto sperm chromatin in
whole Xenopus extract, the full reconstituted reaction and
the reconstituted reaction lacking RLF-B/Cdt1. The reconsti-
tuted reactions contained 2.5 mM ATP.
Figure 5
Requirements for Cdt1 and geminin association with chro-
matin. a, b,Xenopus sperm nuclei were incubated with the
indicated proteins in the presence of 2.5 mM ATP. Chroma-
tin was then isolated and immunoblotted for the presence of
bound Orc1, Cdt1 and geminin. The RLF-B/Cdt1 was a
slightly more active fraction taken from the geminin bead elu-
ate.BMC Biochemistry 2001, 2:15  http://www.biomedcentral.com/1471-2091/2/15
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ferent nucleotides. ORC loading was weak in the absence
of any nucleotide, but was strongly stimulated by ADP,
ATP or ATP-γ -S. In S. cerevisiae, ORC binds specifically
to origin DNA in the presence of ATP or ATP-γ -S [43,44],
though data about ADP has not been published. Cdt1
binding to chromatin was low in the absence of nucle-
otide, and was only slightly stimulated by the presence of
ADP, despite ORC binding becoming maximal. Further
stimulation of Cdt1 binding was seen in the presence of
ATP, as origin licensing occurred. However, the highest
level of Cdt1 binding was seen in samples containing
both ATP and geminin, or in samples containing ATP-γ -
S, conditions when licensing did not occur (Fig 6b). This
is similar to previous results suggesting that ORC and
Cdc6 become destabilised at origins once licensing has
occurred [22].
In order to investigate the requirement for nucleotides in
the binding of Cdc6 to chromatin, we used a crude ex-
tract, from which most nucleotides and other small mol-
ecules had been removed by gel filtration. Consistent
with the results obtained with the purified proteins, gel-
filtered extracts only supported efficient origin licensing
when supplemented with hydrolysable ATP (Fig 7a).
High levels of Cdc6 binding to chromatin were seen only
in samples containing both ATP and geminin, or in sam-
ples containing ATP-γ -S (Fig 7b). Under these conditions
no licensing occurred (Fig 6a, 7a) and high levels of Cdt1
were bound to chromatin (Fig 6b). The lack of strong
Cdc6 binding in the presence of ATP is consistent with
our previous results showing that Cdc6 does not bind
tightly to chromatin once licensing has occurred ("licens-
ing-dependent origin inactivation") [22,45]. Taken to-
gether, these results suggest a model where high levels of
Cdc6 and Cdt1 bind to chromatin only in the presence of
nucleotide triphosphate (ATP or ATP-γ -S), but where the
affinity of both proteins is reduced as a consequence of li-
censing.
Discussion
A significant amount of work in both Xenopus and yeast
has detailed the sequential deposition of ORC, Cdc6,
RLF-B/Cdt1 and finally Mcm2-7 onto replication origins
early in the cell cycle [5–8,10,14,15,17–20,24,46–49].
However, the licensing reaction has not before been re-
constituted with purified proteins, which is a pre-requi-
site for a proper biochemical analysis of the reaction.
Here we describe the results of a systematic purification
of the proteins which have allowed us to license Xenopus
sperm nuclei with purified proteins.
Figure 6
Nucleotide requirements of the reconstituted reaction.
Xenopus sperm nuclei were incubated with nucleoplasmin,
ORC, Cdc6, RLF-B/Cdt1, Mcm2-7 plus or minus geminin in
the presence of either ADP, ATP, ATP-γ -S at 2.5 mM, or no
added nucleotide. a, The degree of functional licensing was
assessed, expressed as % of the DNA template replicated. b,
Chromatin was isolated and immunoblotted for the presence
of Orc1, Cdt1, Mcm3 and geminin. The Mcm2-7 was a
slightly more active fraction taken from the gel filtration step
in the purification, and the RLF-B/Cdt1 was from the geminin
bead eluate.
Figure 7
Nucleotide requirement for Cdc6 chromatin association in
desalted extracts. Sperm nuclei were incubated in desalted
whole egg extract plus or minus geminin in the presence of
either ADP, ATP, ATP-γ -S at 2.5 mM, or no added nucle-
otide. a, The degree of functional licensing was assessed,
expressed as % of the DNA template replicated. b, Chroma-
tin was isolated and immunoblotted for the presence of
Cdc6.BMC Biochemistry 2001, 2:15  http://www.biomedcentral.com/1471-2091/2/15
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Reconstitution of licensed origins with purified proteins
We have shown that licensed replication origins can be
efficiently assembled on Xenopus sperm nuclei using a
combination of nucleoplasmin, ORC, Cdc6, RLF-B/Cdt1
and Mcm2-7. The reconstitution was assessed in two
separate ways: first by a functional assay where the initi-
ation of DNA replication is strictly dependent on the
presence of licensed replication origins as originally de-
fined in Xenopus egg extracts [4,40,41], and secondly by
assessing the loading of Mcm3 and Mcm7 onto chroma-
tin. The requirement of all these proteins is consistent
with previous work on the assembly of replication origins
in a number of eukaryotic organisms. However, it is cur-
rently unclear whether this set of proteins (excluding nu-
cleoplasmin) will also generate the pre-RC footprint over
replication origins in S. cerevisiae, as this may well in-
volve other proteins [13,47].
We provide three lines of evidence strongly suggesting
that no other undetected activities contaminating our
purified proteins play an essential role in origin licens-
ing. First, during our extensive fractionation of Xenopus
egg extracts [[5,8,15,16,19,24,27] and data not shown],
we have not detected any unidentified fractions that sig-
nificantly stimulate origin licensing. Second, the pro-
teins we used have been purified in a number of different
ways and contained only a small number of visible con-
taminating proteins. Third, the efficiency of the reconsti-
tuted reaction was high, resulting in ~18–28% of
potential origins being functionally licensed. In order to
minimise the risk of introducing contaminants into the
assay, all the individual activities were used at limiting
quantities, giving 20–80% licensing of template DNA.
The efficiency of the reconstituted reaction was therefore
not significantly lower than the activities of the individu-
al components, strongly suggesting that no other activi-
ties are required. Although it is never possible to prove
that purified proteins do not contain functionally impor-
tant contaminants, we believe that these three independ-
ent lines of evidence strongly argue against a
requirement for other proteins in the reconstitution.
The purified ORC we used was devoid of visible Orc6, but
despite this, could efficiently support replication licens-
ing in both crude and purified assays. This strongly sug-
gests that Orc6 is not required for origin licensing. It is
also noteworthy that no homologue of the S. cerevisiae
Mcm10/Dna43 protein was required for the reconstitu-
tion. Mcm10/Dna43 is required for the initiation of DNA
replication, in S. cerevisiae, and a recent report has
shown that when temperature-sensitive mutants of
MCM10/DNA43 are moved to the restrictive tempera-
ture in G1, Mcm2 is released from the chromatin [50].
Since we find no requirement for Mcm10/Dna43 for
Mcm2-7 loading, one possible interpretation of this re-
sult is that Mcm10/Dna43 is required for stabilisation,
rather than establishment, of Mcm2-7 complexes on
chromatin.
Stages of origin assembly
The DNA in Xenopus sperm nuclei is held in a tightly
condensed state by the sperm basic proteins. Removal of
these protamines from the sperm DNA, mediated by nu-
cleoplasmin [25], is necessary for ORC to bind to the
DNA [24] (Fig 8a,b). This step is almost certainly unique
for sperm nuclei, as most other nuclear templates do not
contain abundant protamines. We have shown that the
binding of ORC to decondensed sperm chromatin re-
quired the presence of nucleotides (Fig 8c). This require-
ment could be fulfilled by ATP, ATP-γ -S or ADP. In S.
cerevisiae and Drosophila, ORC, the specific binding of
ORC to origin DNA is dependent on ATP or non-hydro-
lysable ATP analogues [43,44,51], though the ability of
ADP to substitute for this function has not been de-
scribed.
Once ORC binding has occurred, Cdc6 and RLF-B/Cdt1
can be recruited to the DNA (Fig 8d) [14,17,18,52]. The
binding of Cdt1 and Cdc6 to ORC-containing DNA can
occur independently of one another [[17,18] and this pa-
per]. We show that the recruitment of Xenopus Cdc6 to
chromatin required ATP or a non-hydrolysable ATP an-
alogue, consistent with results obtained with S. cerevi-
siae Cdc6 [52,53]. However, it is currently unclear
whether the ATP needs to bind ORC or Cdc6 to promote
Cdc6 binding [47,48]. We also show for the first time that
the binding of RLF-B/Cdt1 to chromatin is stimulated by
ATP or ATP-γ -S. Quantitation of the purified RLF-B/
Cdt1 suggested that one molecule could license ~35 kb
DNA, which is expected to contain 3–4 origins. One pos-
sible explanation for the full activity of sub-stoichiomet-
ric amounts of RLF-B/Cdt1 is that it can be rapidly
released from replication origins (perhaps coupled to
ATP hydrolysis), so that one molecule of RLF-B/Cdt1 can
act sequentially at a number of different origins.
The final step in assembling a licensed origin is the as-
sembly of Mcm2-7 onto chromatin (Fig 8e). This step re-
quires ATP hydrolysis [5,53] and can lead to the binding
of 10–20 copies of Mcm2-7 to each origin [39,54,55].
Once Mcm2-7 loading has occurred (which depends on
ORC, Cdc6 and RLF-B/Cdt1), their continued binding to
DNA does not require the continued presence of ORC or
Cdc6 [20–22]. Indeed, the affinity of Cdc6 [22] and RLF-
B/Cdt1 (this paper) for chromatin appears to drop once
licensing is complete, and maximal levels of these pro-
teins on chromatin are only seen when origin licensing is
blocked and in the presence of ATP or ATP-γ -S (Fig 8f).
This process, which we have termed "licensing-depend-
ent origin inactivation" [22] does not depend on laterBMC Biochemistry 2001, 2:15  http://www.biomedcentral.com/1471-2091/2/15
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steps in initiation such as CDK or Cdc7 activation [45],
and seems to occur in the reconstituted reaction.
Regulation of Origin Licensing
Origin licensing can be inhibited in at least two ways
[1,2,12]: work in yeast has shown that Cdk activity late in
the cell cycle is necessary to prevent the re-licensing (and
hence re-firing) of replicated origins, whereas recent
work in Xenopus has shown that inhibition of RLF-B/
Cdt1 by geminin is also a physiologically important
mechanism in regulating the replication licensing sys-
tem during the cell cycle [19,23,37]. We show here that
geminin can inhibit origin licensing in the fully reconsti-
tuted system, suggesting that inhibition by geminin does
not require the presence of any other factor. We also
show that geminin is also recruited to chromatin in the
reconstituted system, and that this is dependent on ORC
and RLF-B/Cdt1, but not on Cdc6. The reconstituted re-
action should allow us to explore in detail the way that
geminin and CDKs regulate the assembly of different or-
igin components during the cell division cycle.
Conclusions
This work shows that origin licensing and Mcm2-7 load-
ing can be reconstituted on Xenopus sperm nuclei with a
combination of nucleoplasmin, ORC, Cdc6, RLF-B/Cdt1
and Mcm2-7. The ORC used in the reconstituted reaction
apparently lacked the Orc6 subunit, suggesting that it is
not required for replication licensing. The reaction re-
quired hydrolysable ATP, though ORC loading could be
promoted by ADP, and the loading of Cdc6 and RLF-B/
Cdt1 could be promoted by ATP-γ -S. The reconstituted
reaction could also be directly inhibited by geminin. The
demonstration that the origin licensing and Mcm2-7
loading can be reconstituted with purified proteins now
opens the way for a detailed biochemical analysis of this
reaction.
Materials and Methods
Preparation of extracts and DNA templates
Metaphase-arrested Xenopus egg extracts were prepared
as described [56]. They were supplemented with 250 µg/
ml cycloheximide, 25 mM phosphocreatine, 15 µg/ml
creatine phosphokinase, and [α -32P]dATP as appropri-
ate, and were then released into interphase with 0.3 mM
CaCl2. To make "6-DMAP extract" for licensing assays,
extracts were supplemented with 3 mM 6-dimethylami-
nopurine (6-DMAP) prior to being released into inter-
phase with CaCl2[40,56]. Immunodepletion of
interphase extracts with antibodies against Orc1, Cdc6,
Mcm3+7 was performed as described [56].
Desalted interphase extract was prepared as follows: 2
ml pre-swollen Sephadex G-25 (Amersham Pharmacia
Biotech) was packed into a column and equilibrated in
LFB1 (40 mM Hepes KOH pH 8.0, 20 mM K2HPO4/
KH2PO4 pH 8.0, 2 mM MgCl2, 1 mM EGTA, 2 mM DTT,
10% (w/v) sucrose and 1 µg/ml each of leupeptin, pepsta-
tin and aprotinin) supplemented with 50 mM KCl (i.e.
LFB1/50). The column was tested for the separation of
bulk protein from [α -32P]dATP. 200 µl of metaphase ex-
tract supplemented with cycloheximide was released
into interphase with CaCl2 for 15 min at 23°C. Extract
was then applied to the Sephadex G-25 column under
gravity and 80 µl drip fractions were collected. 5 frac-
tions, from the peak of protein elution were collected,
Figure 8
Stages in the assembly of licensed replication origins on
sperm nuclei. A cartoon of a small segment of Xenopus
sperm DNA is shown following exposure to egg cytoplasm.
Nucleotide requirements are shown on the right. a, Con-
densed sperm chromatin, with H2A and H2B replaced by
protamines. b, Removal of protamines by nucleoplasmin. c,
Assembly of ORC onto origins, requiring ADP, ATP or ATP-
γ -S. d, Assembly of Cdc6 and RLF-B/Cdt1 onto ORC-con-
taining DNA, requiring ATP or ATP-γ -S. e, The loading of
Mcm2-7 hetero-hexamers onto chromatin represents origin
licensing. 10–20 copies of Mcm2-7 can be assembled onto
each origin. This step requires hydrolysable ATP. f, Once
licensing is complete, the affinity of Cdc6 and RLF-B/Cdt1 for
origins is decreased (licensing-dependent origin inactivation).BMC Biochemistry 2001, 2:15  http://www.biomedcentral.com/1471-2091/2/15
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pooled and stored under liquid nitrogen in 20 µl beads
until required. The final extract recovered was diluted
~3-fold.
"Licensing factor extract", which was used as the starting
point for all the purifications was prepared as described
[5,56]. Briefly, eggs were activated for 5 min by the calci-
um ionophore A23187, before being spin-crushed in
buffer lacking EGTA. Recovered cytoplasm was diluted
1:5 with LFB1/50 and re-centrifuged at 20,000 rpm for
30 min in an SW41 swinging bucket rotor (Beckman).
The clarified supernatant was frozen and stored at -80°C
until required.
Demembranated Xenopus sperm nuclei were prepared
as described [56] and frozen in aliquots in liquid nitro-
gen. Unlicensed "6-DMAP chromatin" [56] was assem-
bled by incubating sperm nuclei for 15 min at 23°C in 6-
DMAP treated extracts at 30,000 nuclei / µl; extract was
then diluted 10-fold in nuclear isolation buffer (NIB: 50
mM KCl, 50 mM Hepes KOH pH 7.6, 5 mM MgCl2, 2 mM
DTT, 0.5 mM spermidine 3HCl, 0.15 mM spermine
4HCl, 1 µg/ml each of leupeptin, pepstatin and apro-
tinin), and underlayered with 100 µl of the same buffer
containing 15% sucrose. The chromatin was pelleted at
6,000 g in a swinging bucket rotor at 4°C for 5 min. The
diluted extract was then removed and the chromatin pel-
let was resuspended in NIB and frozen in aliquots in liq-
uid nitrogen.
Purification of proteins
Nucleoplasmin was purified from "licensing factor ex-
tract" by the protocol of Sealy et al. [28]. RLF-B/Cdt1 was
purified as described by Tada et al. [19]. Because of the
very low quantity of RLF-B/Cdt1 produced, protein con-
centration was roughly estimated using quantitative
Western blotting. For some assays (as indicated) the elu-
ate from the geminin affinity column was used instead of
the final gel filtration material. Recombinant Xenopus
∆ Cdt1 was prepared using the bacterial expression con-
struct described by Maiorano et al. [18]. Inclusion bodies
prepared from E. coli 4 hr after induction were solubi-
lised in 8 M urea and purified on Nickel NTA agarose
(Qiagen) in the presence of 8 M urea. The eluate was di-
alysed sequentially against THED/400 buffer (20 mM
Hepes-KOH pH 8, 20% ethylene glycol, 1 mM dithioth-
reitol, 0.03% Triton X-100 plus 400 mM KCl) containing
urea at 8 M, 4 M, 2 M, 1 M, and finally 0 M. Recombinant
Xenopus Cdc6 was prepared using the baculovirus ex-
pression construct described by Coleman et al. [14]. Cell
lysate prepared from infected Sf21 insect cells was puri-
fied on Nickel NTA agarose as described for ∆ Cdt1, and
finally dialysed into 150 mM NaCl, 20 mM Tris Cl pH 7.5,
1 mM DTT, 5% glycerol, 0.01% Triton X-100. Xenopus
Mcm2-7 protein was purified as described by Gillespie
and Blow [24]. MQ1 and MQ3 peaks were mixed in a ra-
tio of 62:38. For some assays (as indicated) the fractions
from the gel filtration column were used instead of the
MonoQ eluate. Recombinant geminin was prepared in E.
coli as described by McGarry and Kirschner [37].
Xenopus ORC was purified by a modification of the pro-
tocol described by Rowles et al. [15]. 160 ml of "licensing
factor extract" was precipitated with 4.25% polyethylene
glycol, resuspended in 50 ml LFB1 plus 150 mM KCl
(LFB1/150), and mixed for 15 min at 4°C with 12.5 ml
phosphocellulose (Whatman P11) equilibrated in LFB1/
150. The slurry was poured into a column, washed with
LFB1/150 until the UV signal dropped, and activity was
eluted by step in LFB1/500. The eluate was then precip-
itated with 43% (w:v) ammonium sulphate, and the pel-
let resuspended in 910 µl LFB1/50 plus 2.5 mM Mg-ATP
and 0.01% Triton X-100. 4 ×  220 µl aliquots were frac-
tionated on a 24 ml Superose 6 gel filtration column
(Amersham Pharmacia Biotech) run at 0.25 ml / min in
LFB1/50 plus 0.01% Triton X-100. 2 ×  500 µl fractions
from each run containing the UV absorbance peak at
~550 kDa were pooled. The combined gel filtration frac-
tions were applied at 100 µl / min to a 1 ml MonoQ col-
umn (Amersham Pharmacia Biotech) equilibrated in
LFB1/130, and protein eluted in a gradient to LFB1/330
over 20 ml (500 µl fraction size). Fractions containing
Orc1 at ~225 mM KCl (confirmed by dot-blotting) were
pooled, diluted 1:1 with LFB1 plus 0.01% Triton X-100,
and loaded onto a column prepared with 800 µl heparin-
agarose FF (Amersham Pharmacia Biotech) equilibrated
in LFB1/100. The column was developed with a 2.4 ml
gradient to LFB1/450 (flow rate 100 µl/min, fraction size
100 µl). Fractions at ~310 mM KCl containing purified
ORC (as determined by SDS-PAGE and Coomassie stain-
ing) were pooled and diluted 1:3 in LFB1/10 (4.23 ng
ORC / µl).
Assays for individual activities
The assays for ORC, Cdc6 and Mcm2-7 activity were per-
formed by incubating 2.5 µl test samples (purified pro-
tein diluted in 20 mM Hepes KOH pH 8.0, 10 mM KCl, 2
mM DTT, 10% (w:v) sucrose and 1 µg/ml each of leupep-
tin, pepstatin and aprotinin) with 2.5 µl egg extract de-
pleted of ORC, Cdc6 or Mcm2-7 and 0.5 µl Xenopus
sperm nuclei (70 ng DNA / µl) for 30 min; the reaction
was then added to 12.5 µl 6-DMAP-treated extract
[40,56] supplemented with [α -32P]dATP, and the incu-
bation continued for a further 90 min. Total DNA syn-
thesis was determined by TCA precipitation [56]. The
assay for nucleoplasmin activity was performed exactly
as described [24]. In brief, 0.3 µl Xenopus sperm nuclei
(70 ng DNA / µl) plus 1 µl of a crude fraction containing
ORC, Cdc6 and RLF-B/Cdt1 (1.5×  BPAS diluted in LFB1/
50 + 5 mM Mg-ATP) [16,24,56] plus 1 µl of a crude frac-BMC Biochemistry 2001, 2:15  http://www.biomedcentral.com/1471-2091/2/15
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tion containing Mcm2-7 (SP Sepharose eluate) [24] and
1 µl purified nucleoplasmin were incubated for 30 min;
the reaction was then added to 6 µl 6-DMAP-treated ex-
tract and processed as above. The assay for RLF-B activ-
ity was performed by incubating 3 µl test samples
(purified RLF-B diluted in TAB/I 00 buffer) (TAB/100:
2.5 mM Mg-ATP, 4 mg / ml bovine serum albumin,
0.02% Triton-X 100 plus 100 mM KCl) with 2 µl crude
Mcm2-7 (Q Sepharose eluate) [24] and 0.5 µl "6-DMAP
chromatin" (50 ng DNA / µl) for 30 min; the reaction was
then added to 6-DMAP-treated extract and processed as
above.
Reconstitution
The reconstituted reaction consisted of 0.4 µl purified
nucleoplasmin (340 ng / µl), 0.9 µl purified ORC (4.2 ng
/ µl), 0.7 µl purified Cdc6 (50 ng / µl), 2 µl Mcm2-7 (17
ng / µl), and 1 µl of either purified RLF-B/Cdt1 or ∆ Cdt1
(8.7 ng / µl) and 0.5 µl demembranated Xenopus sperm
nuclei (70 ng DNA / µl). ATP, ATP-γ -S and ADP were
added to a final concentration of 2.5 mM as required.
Some reactions were supplemented with 0.5 µl geminin
(15 ng / µl). When individual components were removed,
the volume was made up with the appropriate buffer for
each protein. Reactions were performed for 30 min at
23°C. For assessment of functional licensing, the reac-
tions were added to 12.5 µl 6-DMAP-treated extract sup-
plemented with [α -32P]dATP, and the incubation
continued for a further 90 min. Total DNA synthesis [de-
pendent on the degree of licensing that had occurred,
[40]] was determined by TCA precipitation [56].
For chromatin blotting experiments, the reconstitution
reactions were scaled up 10×  to 50 µl. After the 30 min li-
censing incubation, each reaction was diluted in 400 µl
NIB supplemented with 0.1% Triton X-100, and under-
layered with 120 µl of the same buffer containing 10% su-
crose. The chromatin was pelleted at 2,500 g for 15 min
in a swinging bucket rotor at 4°C (Megafuge; Heraeus).
The diluted extract was removed and the chromatin pel-
let was resuspended in 6×  SDS-PAGE loading buffer. The
samples were run on 4-12% Bis-Tris gradient gels (Novex
/ Invitrogen). The portion of the gel below the 25 kDa
marker was cut off and stained with Coomassie to check
the level of histones H3 and H4 as a control for chroma-
tin recovery; the remainder of the gel was analysed by
immunoblotting.
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